Home
Contact Us
Aggregated China Business Blogs
2021-01-28
Guosen Securities maintains Tiger Pharma's buy rating: the main business continues to recover and non-recurring returns are relatively high
Aggregated Source:
Caishen.Co
Caishen.Co delivers
Primary Data for China`s Secondary Investment and Stock Markets
. Full details at
Caishen.Co
.
Original URL:
Click here to visit original article
Copyright
Caishen.Co
Related Posts
*ST Silver Billion: Progress in the implementation of the “Restructuring Investment Agreement”-
Check Point sees ‘fantastic’ year ahead even as rivals report disappointing billings
Failing to register the equity change to the company as agreed in the agreement, Wansheng shares sued the transferor Fang Haida Digital Model_New Third Board News_New Third Board Market_中金在线
Live news updates: Hong Kong launches $3.8bn scheme to stem professional exodus
Today’s opening: Shanghai Stock Exchange Index reported 3605.36 points, a decrease of 0.04%
China military manoeuvres prompt air rage
US-China Tech Race: shock and awe
China strengthens warning to US about Pelosi’s planned Taiwan trip
Huawei CFO accused of fraud by US authorities
TPG Appoints Zubin Irani To Senior Role In Asia-Pacific
SEARCH
Browse News
January 2021
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Dec
Feb »
Useful Sites
China Media Blog
China Legal Blog
China Travel Blog
Caishen.Co
ChinaPulse.com
ZhongjintouX.com